SGI Stock Forecast & Price Target

Somnigroup International is positively viewed because the LEG acquisition materially expands revenue and earnings power, lifting 2026 guidance to $8.80-$8.85B of revenue, $1.51B of adjusted EBITDA, and $2.95-$3.25 of EPS, while also supporting a stated $5.15 EPS target by 2028. The company expects about $75M of annual synergies from sourcing, operations, and innovation, with additional accretion from LEG before synergies and a lower leverage ratio that should enable faster buybacks later in 2H. Its premium branding and merchandising initiatives around LEG springs, plus tougher supplier standards at Mattress Firm that shift more business to LEG, create a credible path to share gains even as management notes softer industry trends.

Somnigroup International is facing a fundamentally weak demand backdrop, with the mattress industry declining for 4 straight years (2022-2025) and potentially entering a 5th year, while consumer sentiment sits near a 10-year low and store traffic remains the key bottleneck. The company’s own updated guidance reflects this pressure, cutting implied net sales by $200M to about ~$7.6B and reducing adjusted EPS expectations to $2.85-$3.15, with lower growth assumptions across all segments. While gross margin is still expected to exceed 45% from operational efficiencies and synergies, risks from commodity costs, competition, retailer relationships, macro changes, and execution in geographic expansion continue to outweigh the positives.